Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Novocardia

Explore full profile

Building a network of America’s leading cardiologists to improve cardiovascular health across America

New York City, United StatesFounded 2020Health Tech & Medtech
Valuation $250–500M Last recorded · 2021
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Novocardia and the history behind them.

About Novocardia

Novocardia is a pioneering startup in the healthcare sector, specifically focusing on cardiovascular care. The company is dedicated to improving cardiac health across America by building a nationwide network of top cardiologists. Novocardia operates in the value-based care market, which means they focus on providing high-quality care while keeping costs reasonable. This approach results in better patient outcomes and higher satisfaction among both patients and clinicians.

The business primarily serves patients with cardiovascular conditions, aiming to deliver the right care at the right time and place. They achieve this through a combination of advanced technology and data analytics. Novocardia uses electronic health records (EHR) and payer claims data to track patient outcomes, healthcare utilization, and costs. This helps them to identify and address patient needs promptly.

One of Novocardia's key offerings is their Care Transitions Intervention, which ensures smooth transitions between different healthcare settings. This helps to prevent unnecessary hospitalizations and emergency room visits, thereby reducing healthcare costs. They also offer a Longitudinal Heart Failure Program, providing comprehensive support for patients with heart failure.

Novocardia's business model revolves around value-based care, where they get paid based on patient outcomes rather than the volume of services provided. This model incentivizes them to keep patients healthy and satisfied. They make money through partnerships with healthcare providers and payers, leveraging their proprietary technology and actuarial models to optimize care delivery and cost management.

In summary, Novocardia is revolutionizing cardiovascular care by combining a network of leading cardiologists with cutting-edge technology and a value-based care approach. This ensures that patients receive high-quality, timely care while keeping costs in check.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2020
Headquarters
New York City, United States
Employees
6
Open positions
None listed
Dealroom signal
60.5/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Business model
SaaS
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Apr 2023 $0 — Cardiovascular Associates of America ↗
SERIES AOther financing Jun 2021 $54M $215M Deerfield —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Novocardia website traffic

Latest recorded traffic for Novocardia is 1.4K monthly website visits, up 0% over the last three months. Novocardia's team declined 87.2% over the past year.

Latest monthly visits1.4K 3-month web change0% 1-year team growth-87.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Deerfield

Other known investors1 additional known investor

  • Cardiovascular Associates of America
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Novocardia on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novocardia’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.